bioAffinity Technologies, Inc. (BIAFW) bonds
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$36.47K
Long-term debt
Net debt
-$2.39M
After $2.43M of cash
Implied interest rate
144.32%
FY2025 interest ÷ average debt
Interest coverage
-238.3×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in bioAffinity Technologies's 10-Q for the period ended Sep 30, 2022
| Issue | Coupon | Amount issued |
|---|---|---|
| Paycheck Protection Program Loan | 1.00% | – |
| Secured Debt | – | $5.04M |
| Short Term Debt | 4.30% | – |
| Unsecured Debt | – | $3.74M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.